528 material Form 8-K filings that 462 companies we cover made with the SEC in January 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
NCR Atleos appointed Andrew Wamser, formerly CFO of BlueLinx, as Executive Vice President and Chief Financial Officer effective January 27, 2025, replacing Paul Campbell, who will remain an employee until April 1, 2025. The filing describes Wamser's pay package and Campbell's severance treatment, and the company said it expects to meet financial targets for its first full fiscal year.
Andrew Wamser's offer letter sets a $550,000 annual base salary and a 100% target cash bonus.
Wamser receives a $2,000,000 equity award in time-based restricted stock units with a three-year cliff vesting schedule, plus a 2025 long-term incentive target of $1,500,000.
Paul Campbell remains an employee until April 1, 2025, and his departure is treated as a termination without cause for severance purposes.
The company will file the Campbell separation agreement as an exhibit to its 10-K for the fiscal year ending December 31, 2024.
On January 13, 2025, Mosaic's Board elected Sonya C. Little and Kathleen M. Shanahan as directors, each for a term expiring at the 2025 annual shareholder meeting. Little joined the Audit Committee and Shanahan joined the Compensation and Human Resources Committee, both effective the same day.
Board elected Sonya C. Little and Kathleen M. Shanahan as directors on January 13, 2025.
Little joined the Audit Committee; Shanahan joined the Compensation and Human Resources Committee.
Each director received a prorated 2024 annual restricted stock unit grant valued at $64,726.
Truist Financial said Vice Chair and Chief Operating Officer Hugh S. "Beau" Cummins III will resign effective immediately, citing material changes to his responsibilities after completion of strategic initiatives including the sale of Truist Insurance Holdings. His enterprise payments duties go to Kristin Lesher and his remaining duties go to CFO Michael B. Maguire, so shareholders face a senior operating leadership change.
Hugh S. "Beau" Cummins III resigns as Vice Chair and Chief Operating Officer, effective immediately, announced January 13, 2025
Resignation is treated as a Good Reason resignation under Truist's severance plan; Cummins remains eligible for his 2024 annual cash incentive award and receives outplacement benefits
Enterprise payments business moves to Kristin Lesher, Senior EVP and Chief Wholesale Banking Officer; remaining responsibilities move to CFO Michael B. Maguire
Sonos said CEO Patrick Spence will step down as CEO and board member effective January 13, 2025, and director Tom Conrad was appointed interim CEO and president. The company said the change is unrelated to its fiscal first quarter results, which will be reported February 6, 2025, and that it has begun a search for a permanent CEO.
Spence stays employed as an advisor through June 30, 2025, and receives a $1,875,000 cash severance payment and accelerated vesting of certain RSUs at that date, subject to a release of claims.
Conrad receives a monthly base salary of $175,000 and restricted stock units with a grant date value of $2.65 million, vesting monthly over his interim service.
Conrad stepped down as chair of the Compensation, People and Diversity & Inclusion Committee; Karen Boone was named chair and Julius Genachowski joined the committee.
Sonos is providing no update on fiscal first quarter results ahead of the February 6, 2025 report.
Bentley Systems appointed James Lee as Chief Operating Officer effective January 13, 2025, after he spent time at Google Cloud and SAP. The company also eliminated the Chief Product Officer position, and Michael M. Campbell will leave on January 21, 2025 under a separation agreement that includes a $1.5 million cash severance payment.
James Lee appointed COO effective January 13, 2025, with a base salary of $400,000 (prorated for 2025) and an initial OTI target of $400,000 (prorated)
Lee to receive a one-time RSU grant with an aggregate value of $7.5 million, plus 2025 annual RSU awards of $488,889 time-based and $488,889 performance-based
Chief Product Officer role eliminated; product development consolidated under CTO Julien Moutte
Michael M. Campbell leaves January 21, 2025 and will receive a $1.5 million cash severance payment
Pediatrix Medical Group said Executive Chair Mark S. Ordan will return as chief executive, effective immediately, succeeding James D. Swift, M.D. The company also said it currently believes it will reach the high end of its $205 million to $215 million 2024 adjusted EBITDA outlook and that the result may exceed that range, which would be an upward move from the prior guidance.
Mark S. Ordan appointed CEO effective immediately, succeeding James D. Swift, M.D., who will assist during the transition
Prior 2024 adjusted EBITDA outlook was $205 million to $215 million; company now expects the high end or possibly more
Fourth quarter and full year 2024 results to be announced February 20, 2025
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.